Key result
Indirect ARDS is linked to higher hospital mortality than direct ARDS in ECMO patients.
Why the study?
The clinical and biological complexity of direct versus indirect ARDS may profoundly affect outcomes in patients receiving ECMO, but differences in characteristics and outcomes were unclear.
Does indirect ARDS compared to direct ARDS affect mortality in severe ARDS patients receiving ECMO?
Cohort (n=152)
Does indirect ARDS compared to direct ARDS affect mortality in severe ARDS patients receiving ECMO?
Among severe ARDS patients receiving ECMO, the indirect ARDS subphenotype is associated with significantly higher short- and medium-term hospital mortality compared to direct ARDS.
Indirect ARDS may increase short-term mortality on ECMO; leaves open whether subphenotype stratification refines patient selection.
Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome caused by direct (local damage to lung parenchyma) or indirect lung injury (insults from extrapulmonary sites with acute systemic inflammatory response), the clinical and biological complexity can have a profound effect on clinical outcomes. We performed a retrospective analysis of 152 severe ARDS patients receiving extracorporeal membrane oxygenation (ECMO). Our objective was to assess the differences in clinical characteristics and outcomes of direct and indirect ARDS patients receiving ECMO. Overall hospital mortality was 53.3%. A total of 118 patients were assigned to the direct ARDS group, and 34 patients were assigned to the indirect ARDS group. The 28-, 60-, and 90-day hospital mortality rates were significantly higher among indirect ARDS patients (all p < 0.05). Cox regression models demonstrated that among direct ARDS patients, diabetes mellitus, immunocompromised status, ARDS duration before ECMO, and SOFA score during the first 3 days of ECMO were independently associated with mortality. In indirect ARDS patients, SOFA score and dynamic compliance during the first 3 days of ECMO were independently associated with mortality. Our findings revealed that among patients receiving ECMO, direct and indirect subphenotypes of ARDS have distinct clinical outcomes and different predictors for mortality.
No takes yet. Share an insight, caveat, or question.
Chiu et al. (2021) conducted a cohort in Severe acute respiratory distress syndrome (ARDS) (n=152). Indirect ARDS vs. Direct ARDS was evaluated on 28-, 60-, and 90-day hospital mortality (p=< 0.05). Indirect ARDS was associated with significantly higher 28-, 60-, and 90-day hospital mortality rates compared to direct ARDS among patients receiving ECMO (all p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: